Evidence-based practice guideline of Chinese herbal medicine for primary open-angle glaucoma (qingfeng -neizhang)
- PMID: 29595636
- PMCID: PMC5895393
- DOI: 10.1097/MD.0000000000010126
Evidence-based practice guideline of Chinese herbal medicine for primary open-angle glaucoma (qingfeng -neizhang)
Abstract
Background: Primary open angle glaucoma (POAG) is a chronic, progressive optic neuropathy. The aim was to develop an evidence-based clinical practice guideline of Chinese herbal medicine (CHM) for POAG with focus on Chinese medicine pattern differentiation and treatment as well as approved herbal proprietary medicine.
Methods: The guideline development group involved in various pieces of expertise in contents and methods. Authors searched electronic databases include CNKI, VIP, Sino-Med, Wanfang data, PubMed, the Cochrane Library, EMBASE, as well as checked China State Food and Drug Administration (SFDA) from the inception of these databases to June 30, 2015. Systematic reviews and randomized controlled trials of Chinese herbal medicine treating adults with POAG were evaluated. Risk of bias tool in the Cochrane Handbook and evidence strength developed by the GRADE group were applied for the evaluation, and recommendations were based on the findings incorporating evidence strength. After several rounds of Expert consensus, the final guideline was endorsed by relevant professional committees.
Results: CHM treatment principle and formulae based on pattern differentiation together with approved patent herbal medicines are the main treatments for POAG, and the diagnosis and treatment focusing on blood related patterns is the major domain.
Conclusion: CHM therapy alone or combined with other conventional treatment reported in clinical studies together with Expert consensus were recommended for clinical practice.
Conflict of interest statement
Funding/support: Open-angle glaucoma (Qingfeng Neizhang) guideline was developed by Beijing Traditional Chinese Medicine Hospital, Capital Medical University, which was commissioned by ophthalmic branch of China Association of Traditional Chinese Medicine. It was funded by the project titled “Guidelines for clinical diagnosis and treatment of Traditional Chinese Medicine (Revision) for POAG” [project number: SATCM-2015-BZ (009)] sponsored by State Administration of Traditional Chinese Medicine and was partially funded by the grant number 7152071 by the Beijing Natural Science Foundation and the grant number 15ZY09 by the Capital Medical University. All members of the guideline development team stated that the preparation of the guideline would be fully independent, there was no conflict of interest among the members of the guideline working team, no fund from drug and device makers, the drugs used were not affected by any manufacturer, and no contact with any interest groups.
The authors have no conflicts of interest statement.
Figures
References
-
- Glaucoma group ophthalmology branch of Chinese medical association. Expert consensus on diagnosis and treatment of primary glaucoma in China (2014). Chin J Ophthalmol 2014;5:382–3.
-
- Liu JQ, Li FM. Practical ophthalmology. 3rd ed. Beijing: People's MedicalHouse; 2010.
-
- Zhao JL, Sui RF, Jia LJ, et al. Survey on people over 50 and living in Shunyi County, Beijing for the investigation of the prevalence of glaucoma and intraocular pressure in normal eyes. Chin J Ophthalmol 2002;38:335–9. - PubMed
-
- Tang YZ, Xiao GS. Chinese Ophthalmology Encyclopedia. Beijing: People's Medical Publishing House; 2011.
-
- Zhuang ZY, Jin ZY. Today's Chinese Medicine Ophthalmology. 2nd ed.Beijing: People's Medical Publishing House; 2011.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
